Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dornase alfa for arterial recanalization after thrombectomy in ischemic stroke
2021-000939-31Phase 2Active
- Sponsor
- Adolphe de Rothschild Foundation Hospital
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of dornase alfa in ischemic stroke, sponsored by Adolphe de Rothschild Foundation Hospital. Started Mar 2021; status: active.
02
Drugs
dornase alfa
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2021-000939-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000939-31.